跳至主要内容
临床试验/NCT04440891
NCT04440891撤回不适用

Application of Transcranial Magnetic Stimulation Coupled With Virtual Reality for Slowing the Rate of Cognitive Decline in Patients With Alzheimer's Disease

Ali Rezai1 个研究点 分布在 1 个国家开始时间: 2019年10月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
Ali Rezai
试验地点
1
主要终点
Cognitive Performance

研究概览

简要总结

This is a randomized sham control study to evaluate how repetitive Transcranial Magnetic Stimulation (rTMS), interactive cognitive training, or the combination of rTMS and cognitive training reduce the cognitive decline of patients diagnosed with Alzheimer's disease

详细描述

Participants may be assigned to one of four experimental arms (1-TMS-Stimulation with X-Torp task, 2-TMS-Stimulation with MindMotion Go, 3-TMS-Sham with X-Torp task, 4-TMS-Sham with MindMotion Go.) The study will be conducted in two phases. During Phase 1, participants will be randomized between experimental conditions 1 and 4. Data will be analyzed upon completion of Phase1 and Phase 2 will commence only if there is efficacy in the TMS arm. During Phase2, participants will be randomized to arms 2 and 3.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or Female between 50-85 years of age
  • •Able and willing to give informed consent
  • •Probable AD consistent with NIA/AA criteria
  • •Modified Hachinski Ischemia Scale (MHIS) score of <= 4
  • •Geriatric Depression Scale (GDS) score of <= 6
  • •Mini Mental State Exam (MMSE) score 18-
  • •The MMSE adjusted scoring instructions may be followed for screening patients as applicable.

排除标准

  • •Unstable medical conditions
  • •Visual impairments
  • •Mobility limitations
  • •Cognition-enhancing medication unless on a stable dosage for at least 3 months before the start of the trial.
  • •History of epilepsy or seizure disorder
  • •History of psychosis
  • •Current thoughts of suicidal ideation or self-harm as assessed by the Columbia-Suicide severity rating scale score
  • •Progressive neurological disorder or focal signs of abnormality on neurological exam as conducted by a neurologist (other than current diagnosis of AD)
  • •Metal implants (excluding dental fillings)
  • •Possible pregnancy
  • •Substance use disorder within the past six months
  • •Have other mental or physical conditions that are inappropriate for study participation at PI's or delegated sub investigator's discretion.
  • •Intake of one or a combination of the drugs that may due to their significant seizure threshold lowering potential

研究组 & 干预措施

TMS-Stimulation with MindMotion Go

Experimental

TMS with VR 2 experimental arm

干预措施: TMS-Stimulation with MindMotion Go (Device)

TMS-Stimulation with X-Torp task

Experimental

TMS with VR 1 experimental arm

干预措施: TMS stimulation with X-Torp task (Device)

TMS-Sham with X-Torp task

Sham Comparator

TMS sham control with VR 1

干预措施: TMS-Sham with X-Torp task (Device)

TMS-Sham with MindMotion Go

Sham Comparator

TMS sham control with sham VR 2

干预措施: TMS-Sham with MindMotion Go (Device)

结局指标

主要结局

Cognitive Performance

时间窗: 6 months after completion study procedure

Change in cognitive task performance over time using the total score on the Mini Mental State Examination (range 0-30)

次要结局

  • Brain MRI(6 months after completion of study procedure compared to screening)
  • Memory Performance(6 months after completion of study procedure compared to screening)

研究者

发起方
Ali Rezai
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ali Rezai

Director

West Virginia University

研究点 (1)

Loading locations...

相似试验